RGS16 and familial pancreatic carcinoma: To test the hypothesis that RGS16 inhibits pancreatic cancer cell migration, we exogenously expressed RGS16 in BxPC-3, PANC-1, and AsPC-1 cells with an adenoviral vector and used wound healing assays to measure cell migration.